Parcion Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Parcion Private Wealth's REGN Position: Q3 2026 in Review
Parcion Private Wealth increased its Regeneron Pharmaceuticals (REGN) stake by 55% in Q3 2026, buying an estimated $428K and bringing the position to 1,589 shares worth $1.2M. The position accounts for 0.07% of the portfolio, ranked #165.
Parcion Private Wealth first reported a position in REGN in Q3 2025 and has held it in 5 quarters since. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Parcion Private Wealth held 1,589 shares of Regeneron Pharmaceuticals worth $1.2M as of Q3 2026.
- Parcion Private Wealth bought 567 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $428K.
- Regeneron Pharmaceuticals made up 0.07% of Parcion Private Wealth's portfolio in Q3 2026, its #165 holding.
- Parcion Private Wealth first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Parcion Private Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.